Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes in Stockholders??? (Deficit) Equity

v3.22.1
Condensed Statements of Changes in Stockholders’ (Deficit) Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 17, 2020
Balance (in Shares) at Jun. 17, 2020      
Net income (loss) (1,000) (1,000)
Balance at Jun. 30, 2020 (1,000) (1,000)
Balance (in Shares) at Jun. 30, 2020      
Sale of 4,312,500 Founder Shares $ 431 24,569 25,000
Sale of 4,312,500 Founder Shares (in Shares) 4,312,500      
Net income (loss)
Balance at Sep. 30, 2020 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Sep. 30, 2020 4,312,500      
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Dec. 31, 2020 4,312,500      
Net income (loss)
Balance at Mar. 31, 2021 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Mar. 31, 2021 4,312,500      
Net income (loss)
Balance at Jun. 30, 2021 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Jun. 30, 2021 4,312,500      
Net proceeds from Initial Public Offering allocated to Rights, net of transaction costs 3,845,969 3,845,969
Excess of cash received over fair value of private placement warrants 4,161,500 4,161,500
Change in fair value of over-allotment option liability 225,000 225,000
Accretion of common stock to possible redemption amount (8,032,038) (7,337,676) (15,369,714)
Net income (loss) (4,438,654) (4,438,654)
Balance at Sep. 30, 2021 [1] $ 431 $ (11,552,330) $ (11,551,899)
Balance (in Shares) at Sep. 30, 2021 [1] 4,312,500      
[1] As restated due to the review of accounting for complex financial instruments and change in fair value of warrant liabilities (see Note 2).